Copper — Drug Target
All drugs that target Copper — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Phase 2 pipeline (1)
- Bis-Choline Tetrathiomolybdate · Alexion Pharmaceuticals, Inc. · Chelating agent · Neurology
Bis-Choline Tetrathiomolybdate is a chelating agent that binds to copper, reducing its availability for incorporation into ceruloplasmin and subsequent deposition in the brain.